Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis.

Tao R, Dai J, Bai Y, Yang J, Sun G, Zhang X, Zhao J, Zeng H, Shen P.

Radiat Oncol. 2019 Nov 9;14(1):197. doi: 10.1186/s13014-019-1384-z. Review.

2.

Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival.

Casas F, Valduvieco I, Oses G, Izquierdo L, Archila I, Costa M, Cortes KS, Barreto T, Ferrer F.

Clin Transl Oncol. 2019 Mar;21(3):355-362. doi: 10.1007/s12094-018-1931-3. Epub 2018 Aug 20.

PMID:
30128953
3.

Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.

Hervás A, Gómez-Caamaño A, Casaña M, Gómez-Iturriaga A, Pastor J, Jove J, Mengual JL, Gónzalez-San Segundo C, Muñoz J.

Clin Transl Oncol. 2018 Feb;20(2):193-200. doi: 10.1007/s12094-017-1709-z. Epub 2017 Jun 30.

PMID:
28667448
4.

Adjuvant and salvage radiotherapy after prostatectomy: a systematic review and meta-analysis.

Chen C, Lin T, Zhou Y, Li D, Xu K, Li Z, Fan X, Zhong G, He W, Chen X, He X, Huang J.

PLoS One. 2014 Aug 14;9(8):e104918. doi: 10.1371/journal.pone.0104918. eCollection 2014. Review.

5.

Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.

Fossati N, Karnes RJ, Boorjian SA, Moschini M, Morlacco A, Bossi A, Seisen T, Cozzarini C, Fiorino C, Noris Chiorda B, Gandaglia G, Dell'Oglio P, Joniau S, Tosco L, Shariat S, Goldner G, Hinkelbein W, Bartkowiak D, Haustermans K, Tombal B, Montorsi F, Van Poppel H, Wiegel T, Briganti A.

Eur Urol. 2017 Jun;71(6):886-893. doi: 10.1016/j.eururo.2016.07.028. Epub 2016 Jul 30.

PMID:
27484843
6.

Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.

Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA.

JAMA Oncol. 2018 May 10;4(5):e175230. doi: 10.1001/jamaoncol.2017.5230. Epub 2018 May 10. Erratum in: JAMA Oncol. 2018 May 1;4(5):751.

7.

Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.

Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A.

Eur Urol. 2018 Apr;73(4):512-518. doi: 10.1016/j.eururo.2017.11.020. Epub 2017 Dec 8.

PMID:
29229176
8.

Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.

Thompson IM, Valicenti RK, Albertsen P, Davis BJ, Goldenberg SL, Hahn C, Klein E, Michalski J, Roach M, Sartor O, Wolf JS Jr, Faraday MM.

J Urol. 2013 Aug;190(2):441-9. doi: 10.1016/j.juro.2013.05.032. Epub 2013 May 21.

PMID:
23707439
9.
10.

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.

Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):755-63.

PMID:
12788182
11.

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.

Pearse M, Fraser-Browne C, Davis ID, Duchesne GM, Fisher R, Frydenberg M, Haworth A, Jose C, Joseph DJ, Lim TS, Matthews J, Millar J, Sidhom M, Spry NA, Tang CI, Turner S, Williams SG, Wiltshire K, Woo HH, Kneebone A.

BJU Int. 2014 Mar;113 Suppl 2:7-12. doi: 10.1111/bju.12623.

12.

[Adjuvant vs. salvage radiotherapy after radical prostatectomy].

Bartkowiak D, Schrader AJ, Wiegel T.

Aktuelle Urol. 2015 Jan;46(1):52-8. doi: 10.1055/s-0034-1395656. Epub 2015 Feb 6. Review. German.

PMID:
25658231
13.

Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.

Briganti A, Wiegel T, Joniau S, Cozzarini C, Bianchi M, Sun M, Tombal B, Haustermans K, Budiharto T, Hinkelbein W, Di Muzio N, Karakiewicz PI, Montorsi F, Van Poppel H.

Eur Urol. 2012 Sep;62(3):472-87. doi: 10.1016/j.eururo.2012.04.056. Epub 2012 May 16.

PMID:
22633803
14.
15.

Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.

Song C, Kang HC, Kim JS, Eom KY, Kim IA, Chung JB, Hong SK, Byun SS, Lee SE.

Strahlenther Onkol. 2015 Oct;191(10):801-9. doi: 10.1007/s00066-015-0872-9. Epub 2015 Jul 10.

PMID:
26159555
16.

Regression Discontinuity Analysis of Salvage Radiotherapy in Prostate Cancer.

Gild P, Pompe RS, Seisen T, Keeley J, Tang HJ, Bossi A, Tilki D, Menon M, Abdollah F.

Eur Urol Oncol. 2019 Sep 6. pii: S2588-9311(19)30131-2. doi: 10.1016/j.euo.2019.08.005. [Epub ahead of print]

PMID:
31501084
17.

Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy.

Kashihara T, Nakamura S, Wakita A, Okamoto H, Inaba K, Umezawa R, Shima S, Tsuchida K, Kobayashi K, Takahashi K, Murakami N, Ito Y, Igaki H, Fujimoto H, Uno T, Itami J.

Cancer Med. 2018 May;7(5):1723-1730. doi: 10.1002/cam4.1408. Epub 2018 Mar 23.

18.

Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?

Hsu CC, Paciorek AT, Cooperberg MR, Roach M 3rd, Hsu IC, Carroll PR.

BJU Int. 2015 Nov;116(5):713-20. doi: 10.1111/bju.13043. Epub 2015 May 26.

19.

Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer.

Botticella A, Guarneri A, Levra NG, Munoz F, Filippi AR, Rondi N, Badellino S, Arcadipane F, Levis M, Ragona R, Ricardi U.

J Cancer Res Clin Oncol. 2014 Jul;140(7):1111-6. doi: 10.1007/s00432-014-1673-8. Epub 2014 Apr 18.

PMID:
24744191
20.

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.

Gore JL, du Plessis M, Santiago-Jiménez M, Yousefi K, Thompson DJS, Karsh L, Lane BR, Franks M, Chen DYT, Bandyk M, Bianco FJ Jr, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW.

Cancer. 2017 Aug 1;123(15):2850-2859. doi: 10.1002/cncr.30665. Epub 2017 Apr 19.

Supplemental Content

Support Center